Perspective Therapeutics (CATX) Shares Outstanding (2010 - 2026)

Perspective Therapeutics (CATX) has 15 years of Shares Outstanding (Entity) data on file, last reported at $49.5 million in Q1 2024.

• For the quarter ending Q1 2024, Shares Outstanding (Entity) rose 116.59% year-over-year to $49.5 million; the trailing twelve-month figure through Mar 2024 stood at $49.5 million (up 116.59% YoY), and the FY2023 full-year result was $28.2 million, up 98.3% from the prior year.
• Shares Outstanding (Entity) grew to $49.5 million in Q1 2024, from $28.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $49.5 million in Q1 2024 to a low of $6.8 million in Q1 2020.
• A 5-year average of $17.4 million and a median of $14.2 million in 2021 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 0.05% in 2022 and jumped 116.59% in 2024, its largest moves.
• Tracing CATX's Shares Outstanding (Entity) over 5 years: stood at $8.7 million in 2020, then soared by 62.83% to $14.2 million in 2021, then increased by 0.05% to $14.2 million in 2022, then soared by 98.3% to $28.2 million in 2023, then jumped by 75.69% to $49.5 million in 2024.
• Business Quant data shows CATX's Shares Outstanding (Entity) at $49.5 million in Q1 2024, $28.2 million in Q4 2023, and $28.1 million in Q3 2023.